Quick answer
How should the KLOW Stack be stored? The product page states 2–8 °C for refrigerated holding and −20 °C for long-term storage, protected from heat, moisture and light. No validated shelf life is published for the powder or any solution, so labs should log dates, limit time in solution, freeze single-use portions once, and re-verify concentration by HPLC when results depend on it. For laboratory research use only.
A four-peptide blend is stored as one object but degrades as four. That single fact drives every decision in this guide: the KLOW Stack vial holds GHK-Cu, KPV, BPC-157 and TB-500 co-lyophilized together, so a storage condition that suits one component has to be tolerable for the other three. This page explains the temperature, light and time questions around that vial, using the conditions published on the KLOW Stack product page and general peptide-stability literature. For laboratory research use only; not for human consumption.
It is deliberately narrow. Mixing arithmetic and step-by-step dissolving are covered in KLOW Stack reconstitution and storage, and component biology is in the KLOW Stack research guide. Here the question is only: once the vial is on the shelf or in the freezer, what is happening to it, and what should the lab record?
What the product page states about storage
The KLOW Stack page describes a lyophilized powder in a sealed clear glass research vial, 80 mg of total blend per vial, with purity stated as ≥98% by HPLC. The storage line reads: refrigerate at 2–8 °C, −20 °C for long-term storage, and protect from heat, moisture and light. The page does not give a validated shelf life for the dry powder or for any reconstituted solution, and this article does not invent one.
| Condition | Stated on the product page | What it means for planning |
|---|---|---|
| Near-term holding | 2–8 °C | Working stock for an experiment series that starts within the planning window |
| Long-term holding | −20 °C | Reserve vials that will not be opened soon |
| Heat | Protect from heat | Do not leave vials on a bench near instruments or in a warm receiving area |
| Moisture | Protect from moisture | Keep the stopper sealed; let the vial warm before opening |
| Light | Protect from light | Keep in the original box or an opaque secondary container |
A statement of conditions is not a statement of time. When a study depends on the blend being unchanged, the vial's date of receipt, the date it was first opened and every temperature excursion belong in the lab record next to the lot identifier. The COA page and how to read a COA explain what batch documentation does and does not establish.
Why a co-lyophilized blend is different from a single peptide
A single-peptide vial has one chemistry to protect. A co-lyophilized blend is a shared solid in which four molecules sit side by side with a copper complex. Lyophilization removes water by sublimation and leaves a porous, amorphous solid; the general logic of that design, and why it protects peptides, is covered in what is lyophilization. Reviews of protein stability handle stabilization in the dried state as a topic distinct from stability in aqueous solution, which is why a dry vial and a dissolved solution need different handling and different time limits [1].
Two practical consequences follow for a blend. First, the vial has no reservoir of inert filler specific to any one component, so moisture that enters through a poorly seated stopper is shared by all four. Second, the dry cake is often a blue color, because the copper complex of GHK-Cu dominates the appearance of the powder. A blue cake is expected and says nothing, good or bad, about the other three peptides, so color cannot be used as a quality check for the whole mixture.
Temperature: what the 2–8 °C and −20 °C tiers protect against
Chemical degradation rates in peptides generally fall as temperature falls, which is the reason for two storage tiers. Reviews of peptide and protein stability describe the main routes: hydrolysis, deamidation, oxidation and aggregation, each with its own temperature dependence [1, 2]. The relevant routes differ by component.
- KPV is a three-residue peptide with proline in the second position. Model-peptide work has shown that small peptides with an internal proline can cyclize to a diketopiperazine, and that the reaction rate rises with pH [4]. That study used a different tripeptide (Ala-Pro-Met) at 37 °C, so it is evidence for a mechanism, not a measured rate for KPV.
- Methionine-containing and tryptophan-containing sequences are the usual oxidation sites in the literature [1]. Among the four components, the amount of such residues differs, which is one reason component-level analysis of an aged blend is more informative than a single total-purity figure.
- The whole mixture can also change by interaction. Metal-catalyzed oxidation is a documented damage route in proteins [3], and GHK-Cu is by definition a metal-containing component sitting in the same solid as three others.
None of these studies tested the KLOW blend, so they should be read as reasons for caution, not predictions. The practical rule they support is simple: colder and drier is safer, and each warm-up and refreezing adds risk.
| Degradation route | Why it matters for a four-peptide blend | Handling response |
|---|---|---|
| Moisture uptake | Shared by all components; accelerates every chemical route | Warm sealed vials to room temperature before opening; reseal promptly |
| Diketopiperazine formation | Documented for model tripeptides with proline; faster at higher pH | Avoid storing solutions at neutral-to-basic pH for long periods |
| Oxidation | Metal ions can catalyze it; the blend contains copper | Limit air exposure and time in solution; avoid adding extra metal sources |
| Aggregation and surface loss | Several peptides in one solution; peptide binding to tube surfaces is documented [5] | Use low-binding tubes and few transfers |
Light: what to do and what is not known
The product page says to protect the vial from light, and that instruction is easy to follow: keep the vial in its box or in an opaque container, and avoid leaving it under bench lights during long weighing or pipetting sessions. What the published literature does not provide is a photostability study for this particular four-component mixture. Forced-degradation studies are the standard tool for finding such sensitivities, and light exposure is one of the stresses they commonly include [6]. Without such data for the blend, protection from light is a precaution, not a measured requirement.
An opaque secondary container also has a second benefit: it makes the vial easier to find in a freezer box and gives a place to attach the log sheet. The log matters more than the light shield, because it is what lets a later reader decide whether a surprising result could be explained by storage history.
Shelf life: how to talk about it honestly
Searches for shelf life usually want a number of months. For this vial no such number is supplied on the product page, and the literature on lyophilized and liquid peptide formulations explains why one number rarely transfers between compounds, buffers and temperatures [1, 2]. A defensible internal policy replaces a number with a procedure:
- Record the date of receipt and the storage tier assigned on arrival.
- Decide before the first opening how many aliquots the study needs, and divide the stock accordingly after dissolving.
- Set a maximum time in solution for the study, write it in the protocol, and discard after it passes.
- If results depend on exact concentration, re-verify the stock by HPLC against a fresh vial instead of trusting age alone. See understanding HPLC purity for what a chromatogram does and does not show.
The same reasoning covers reconstituted material. The reasoning around solution stability, and why it is shorter than powder stability, is developed in how long reconstituted peptides last and storing research peptides.
Freeze–thaw and aliquoting a four-peptide solution
Freezing a solution is not a neutral act. Freeze-thawing is one of the standard stress conditions used in forced-degradation work [6], and stability reviews discuss freezing as a source of physical instability for liquid formulations [1, 2]. A blend multiplies the opportunities: there are four sequences, plus a copper complex, in the same concentrating liquid.
The routine consequence is a one-thaw rule. If a solution has to be kept beyond the same working day, divide it into single-use portions in low-binding tubes, freeze them, and thaw each portion once. Peptide recovery from tubes varies with the surface material, and a published study of radiolabeled peptides found that siliconized tubes reduced, and added bovine serum albumin improved, recovery losses [5], so label the tube with the intended concentration and avoid diluting more than the experiment needs. The arithmetic for how much to add stays a formula: total peptide mass divided by diluent volume gives the overall concentration, and each component's stated mass divided by the same volume gives its own. The reconstitution calculator does the sums, and the figures should be written on the tube.
A short storage log for the KLOW vial
The following fields are enough to reconstruct what happened to a vial, and none requires special equipment:
| Field | Example entry type |
|---|---|
| Lot identifier and receipt date | From the vial label and packing record |
| Appearance on arrival | Blue cake, intact or broken, any wet or collapsed areas (see peptide vial appearance) |
| Tier assigned | 2–8 °C working stock or −20 °C reserve |
| Each opening | Date, time at room temperature, who opened it |
| Solution preparation | Diluent type, volume added, resulting total concentration |
| Aliquots | Count, tube type, freezer position, thaw date |
| Excursions | Power loss, transit delay, door left open |
For component-level identity and purity reporting, KLOW Stack purity testing describes how chromatography is read for a multi-peptide sample, and KLOW Stack research guide summarizes what each component is. If the experiment can be run with the single-component vials instead, such as KPV research vials, the storage question simplifies to one chemistry.
Frequently asked questions
How should the KLOW Stack vial be stored?
The product page states: refrigerate at 2–8 °C, −20 °C for long-term storage, and protect from heat, moisture and light. Keep the stopper sealed until the vial is at room temperature.
Does the KLOW Stack need to be frozen?
The page lists −20 °C for long-term storage and 2–8 °C for refrigerated holding. Which tier is used depends on how soon the vial will be opened; reserve vials go to the freezer.
What does the product page say about shelf life?
It gives storage conditions but no validated shelf life for the powder or for solutions, so a lab should set its own written time limit and record dates.
Why is the powder blue?
GHK-Cu is a copper complex and colors the cake and the solution blue. The color comes from copper and is not an indicator of the other three components.
Is light protection necessary?
The page says to protect the vial from light. No photostability study for this specific blend is cited here, so regard it as a precaution and keep the vial in its box or an opaque container.
How many freeze–thaw cycles can a reconstituted blend take?
Plan for one. Freezing concentrates solutes and creates ice interfaces that can encourage aggregation, so divide into single-use portions and thaw each portion once.
Can a reconstituted blend be kept in the refrigerator?
Short holding in the refrigerator is common practice, but no validated duration is published for this blend. Set a written limit, protect the tube from light and re-verify by HPLC when concentration matters.
Does time at room temperature matter?
Yes, cumulatively. Moisture uptake and chemical degradation both speed up when the vial is warm, so keep each opening brief and log the time out of storage.
Where can stability be checked analytically?
By HPLC against a reference, ideally comparing an aged sample with a fresh vial. Component-level identity requires methods that separate the four peptides; see the KLOW purity testing article.
Related reading: KLOW vs GLOW Stack: What KPV Adds to the Blend, KPV in the KLOW Stack: Gut and Inflammation Research, KLOW Stack Skin and Tissue Models: Evidence by Peptide.
References
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of Protein Pharmaceuticals: An Update. Pharm Res. 2010;27(4):544-575. doi:10.1007/s11095-009-0045-6
- Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. International Journal of Pharmaceutics. 1999;185(2):129-188. doi:10.1016/S0378-5173(99)00152-0
- Stadtman ER. Metal ion-catalyzed oxidation of proteins: Biochemical mechanism and biological consequences. Free Radical Biology and Medicine. 1990;9(4):315-325. doi:10.1016/0891-5849(90)90006-5
- Goolcharran C, Jones AJS, Borchardt RT. Comparison of the rates of deamidation, diketopiperazine formation, and oxidation in recombinant human vascular endothelial growth factor and model peptides. AAPS PharmSci. 2000;2(1):42-47. doi:10.1208/ps020105
- Goebel-Stengel M, Stengel A, Taché Y, Reeve JR. The importance of using the optimal plasticware and glassware in studies involving peptides. Analytical Biochemistry. 2011;414(1):38-46. doi:10.1016/j.ab.2011.02.009
- Hawe A, Wiggenhorn M, van de Weert M, Garbe JHO, Mahler Hc, Jiskoot W. Forced Degradation of Therapeutic Proteins. Journal of Pharmaceutical Sciences. 2012;101(3):895-913. doi:10.1002/jps.22812
